-
-
-
-
-
-
-
NeoGenomics Reports Third Quarter 2025 Results
-
-
-
-
-
-
-
NeoGenomics (NEO) Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
-
-
-
-
-
-
-
NeoGenomics Reports Second Quarter 2023 Results
-
-
-
-
-
-
-
NeoGenomics Reports Revenue of $125 Million in the Second Quarter
-
-
-
-
-
-
-
NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
-
-
-
-
-
-
-
Guardant Health's (GH) Potential Deal for NeoGenomics (NEO) Would Be Dilutive to Top Line - Stifel
-
-
-
-
-
-
-
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
-
1,160,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

